1AD — Adalta Share News
0.000.00%
Last trade - 00:00- AU$9.18m
- AU$7.60m
- AU$0.70m
Australia's AdAlta hits 2-month low on discounted placement
Brief: Adalta To Raise A$2.5 Million
Brief: Adalta Seeks Trading Halt
Brief: Adalta Says Co, Oribiotech, Cell Therapies Sign MOU
Australia's AdAlta soars to over a month high on cancer treatment partnership
Brief: Adalta Says Adcella And Shanghai Cell Therapy Group Launch Global Collaboration
Brief: Adalta Says Resolution 6 Relating To Proposed Share Consolidation Is Withdrawn From 2025 AGM
Brief: Adalta To Raise Up To A$1.3 Mln At 0.3 Au Cents Per Share
Brief: Adalta Seeks Trading Halt
Brief: Adalta Says Synthesis Bioventures To Invest Up To A$2 Million In Unit
Australia's AdAlta climbs on securing $1.3 mln funding for unit
Australia's AdAlta jumps on capital raising
Brief: Adalta Says A$1.9 Million Raised
Brief: Adalta Says Cell Therapies To Be Preferred Manufacturer Of Cellular Immunotherapies
Brief: Adalta Secures Up To A$3.7 Million To Pursue Strategic Initiatives
Australia's AdAlta rises on deal with SYNthesis BioVentures
Brief: Adalta Says Co & Synthesis Bioventures Partner For Development Of Next Generation Cell-Based Immunotherapies
Australia's AdAlta eyes record jump on positive study results for fibrosis drug
Australia's Adalta stumbles on discounted placement